title: Prophylactic antilymphocyte globulin and HLA-DR matching reduce the incidence of rejection after cadaveric kidney transplantation.
authors.affiliation: Department of Internal Medicine, University Hospital Rotterdam-Dijkzigt, The Netherlands.
authors.forename: W
authors.initials: W
authors.lastname: Weimar
authors.forename: G F
authors.initials: GF
authors.lastname: Hendriks
authors.forename: G J
authors.initials: GJ
authors.lastname: Wenting
authors.forename: H H
authors.initials: HH
authors.lastname: Vincent
authors.forename: G M
authors.initials: GM
authors.lastname: Schreuder
authors.forename: J
authors.initials: J
authors.lastname: Jeekel
mesh_terms: D058186:Acute Kidney Injury / Q000517:prevention & control; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D002102:Cadaver; D006084:Graft Rejection; D006681:HLA-D Antigens / Q000032:analysis*; D006684:HLA-DR Antigens / Q000032:analysis*; D006801:Humans; D007165:Immunosuppression Therapy; D007668:Kidney / Q000276:immunology; D016030:Kidney Transplantation
chemical_list: D000961:Antilymphocyte Serum; D006681:HLA-D Antigens; D006684:HLA-DR Antigens